Azcue, N.
Del Pino, R. http://orcid.org/0000-0002-6612-4757
Acera, M.
Fernández-Valle, T.
Ayo-Mentxakatorre, N.
Pérez-Concha, T.
Murueta-Goyena, A.
Lafuente, J. V.
Prada, A.
López de Munain, A.
Ruiz Irastorza, G.
Martín-Iglesias, D.
Ribacoba, L.
Gabilondo, I.
Gómez-Esteban, J. C.
Tijero-Merino, B.
Funding for this research was provided by:
Instituto de Salud Carlos III (PI20/01076)
EITB maratoia (BIOS21/COV/006)
Basque Government (2021111006)
Hezkuntza, Hizkuntza Politika Eta Kultura Saila, Eusko Jaurlaritza (PRE_2022_2_0111)
Article History
Received: 26 September 2023
Accepted: 28 October 2023
First Online: 15 November 2023
Declarations
:
: The study protocol was approved by the Basque Drug Research Ethics Committee [<i>Comité de Ética de la Investigación con medicamentos de Euskadi</i> (CEIm-E) (PI2020210)]. All participants gave written informed consent prior to their participation in the study, in accordance with the tenets of the Declaration of Helsinki.
: All authors give the Publisher permission to publish this work.
: The authors declare that they have no conflict of interest.